Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

NCT05926011 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
108
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

REGEnLIFE SAS

Collaborators